A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 6,531,099 shares of BEAM stock, worth $156 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
6,531,099
Previous 7,626,139 14.36%
Holding current value
$156 Million
Previous $179 Million 10.45%
% of portfolio
1.52%
Previous 1.63%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$22.57 - $33.14 $24.7 Million - $36.3 Million
-1,095,040 Reduced 14.36%
6,531,099 $160 Million
Q2 2024

Jul 26, 2024

SELL
$21.22 - $32.66 $11.8 Million - $18.2 Million
-556,035 Reduced 6.8%
7,626,139 $179 Million
Q1 2024

Apr 18, 2024

SELL
$23.46 - $45.07 $28.4 Million - $54.6 Million
-1,211,715 Reduced 12.9%
8,182,174 $270 Million
Q4 2023

Jan 17, 2024

BUY
$17.69 - $30.76 $10.8 Million - $18.8 Million
609,998 Added 6.94%
9,393,889 $256 Million
Q3 2023

Oct 18, 2023

BUY
$23.01 - $32.46 $9.23 Million - $13 Million
401,296 Added 4.79%
8,783,891 $211 Million
Q2 2023

Jul 10, 2023

SELL
$29.32 - $35.99 $5.6 Million - $6.87 Million
-190,834 Reduced 2.23%
8,382,595 $268 Million
Q1 2023

Apr 17, 2023

BUY
$30.15 - $48.79 $10.9 Million - $17.6 Million
360,298 Added 4.39%
8,573,429 $263 Million
Q4 2022

Jan 24, 2023

SELL
$36.73 - $51.6 $10.2 Million - $14.3 Million
-277,805 Reduced 3.27%
8,213,131 $0
Q3 2022

Oct 17, 2022

SELL
$39.79 - $70.31 $12 Million - $21.2 Million
-301,128 Reduced 3.42%
8,490,936 $405 Million
Q2 2022

Jul 11, 2022

BUY
$29.86 - $62.36 $17.7 Million - $36.9 Million
591,315 Added 7.21%
8,792,064 $309 Million
Q1 2022

Apr 19, 2022

BUY
$53.73 - $82.16 $11.7 Million - $17.9 Million
217,348 Added 2.72%
8,200,749 $470 Million
Q4 2021

Jan 28, 2022

BUY
$68.02 - $99.06 $77.7 Million - $113 Million
1,141,679 Added 16.69%
7,983,401 $636 Million
Q3 2021

Nov 12, 2021

BUY
$84.37 - $133.6 $32.1 Million - $50.8 Million
380,355 Added 5.89%
6,841,722 $595 Million
Q2 2021

Aug 05, 2021

BUY
$64.12 - $128.71 $108 Million - $217 Million
1,682,263 Added 35.2%
6,461,367 $832 Million
Q1 2021

May 13, 2021

BUY
$71.28 - $120.75 $260 Million - $440 Million
3,647,481 Added 322.32%
4,779,104 $383 Million
Q4 2020

Feb 12, 2021

BUY
$22.24 - $95.63 $25.2 Million - $108 Million
1,131,623 New
1,131,623 $92.4 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.68B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.